CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020		59,901,306
Beginning balance at Dec. 31, 2020	$ 16,617	$ 6	$ 537,370	$ (520,759)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation costs	2,185		2,185
Vesting of restricted stock units (in shares)		394,589
Vesting of restricted stock units - Note 16	765		765
Stock issuance - other (in shares)		137,500
Stock issuance – other – Note 14	209		209
5-Year Private Warrants transferred to 5-Year Public Warrants – Notes 12 and 14	294		294
Net loss	(88,564)			(88,564)
Ending balance (in shares) at Dec. 31, 2021		60,433,395
Ending balance at Dec. 31, 2021	(68,494)	$ 6	540,823	(609,323)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation costs	2,456		2,456
Vesting of restricted stock units (in shares)		1,114,962
Vesting of restricted stock units - Note 16	727		727
Stock issuance - other (in shares)		1,852,178
Stock issuance – other – Note 14	1,907		1,907
5-Year Private Warrants transferred to 5-Year Public Warrants – Notes 12 and 14	42		42
Net loss	(60,828)			(60,828)
Issuance of common stock (in shares)		136,870,064
Issuance of common stock and warrants – Note 14	187,496	$ 14	187,482
Ending balance (in shares) at Dec. 31, 2022		200,270,599
Ending balance at Dec. 31, 2022	$ 63,306	$ 20	$ 733,437	$ (670,151)